MedicarePartD.guide

A non-government resource built from CMS public data

TASCENSO ODT .5 mg Tablet, Orally Disintegrating

Also known as Fingolimod Lauryl Sulfate. Coverage in Hawaii (CMS PDP Region 33).

Not on any stand-alone Part D formulary in Hawaii

None of the 8 stand-alone Part D (PDP) plans in CMS PDP Region 33 list this drug. On one of those plans the patient would pay the full retail price, or you would need a formulary exception.

See coverage in all 39 regions →